Tech Company Financing Transactions
Optimer Pharmaceuticals Funding Round
Optimer Pharmaceuticals secured a $34.2 million funding round on 6/30/2005. Backers included CDIB Bioscience, ProQuest Investments and SB Life Science Ventures.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$34,200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Hudson Street 3501
Jersey City, NJ 07302
USA
Jersey City, NJ 07302
USA
Phone
Website
Email Address
Overview
Optimer is currently focused on discovering, developing, and commercializing innovative anti-infective products for treating diseases that currently have no satisfactory therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hank McKinnell
Chief Financial Officer
Stephen Webster
Chief Information Officer
Rachel Stahler
Chief Scientific Officer
Sherwood Gorbach
VP - Bus. Development
Bhooshi Silva
VP - Human Resources
Linda Amper
VP - Operations
Robert Savel
Browse more venture capital transactions:
Prev: 6/30/2005: MerchantCircle venture capital transaction
Next: 6/30/2005: Symwave venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs